Eaton Vance Tax-Managed Global Diversified Equity Income Fund trades at a discount with strong distributions. Learn why EXG ...

专注于治疗罕见疾病的临床阶段生物技术公司 Elixirgen Therapeutics, Inc.宣布，美国食品药品监督管理局 (FDA) 已授予 EXG-34217 孤儿药资格，EXG-34217 是一种用于治疗端粒生物学疾病 (TBD) 的基因疗法。 关于端粒生物学障碍和 EXG-34217 端粒生物学疾病 (TBD) 是一组罕见的 ...

Donald Trump ratcheted up tensions over Ukraine again today - as a senior member of his diplomatic team indicated he agreed that Volodymyr Zelensky is a dictator. The US President gave an ...

BALTIMORE, Feb. 20, 2025 (GLOBE NEWSWIRE) -- Elixirgen Therapeutics, Inc., a clinical-stage biotechnology company focused on treating rare diseases, today announced that the U.S. Food and Drug ...

a clinical-stage biotechnology company focused on treating rare diseases, today announced that the U.S. Food and Drug Administration (FDA) has granted Orphan Drug Designation to EXG-34217 ...

Anyone with information should contact us as soon as possible.” The Mirror have reached out to their reps for comment.